Welcome Ed Gajewski to Nuvera Life Science Consulting!

Nuvera Life Science Consulting is excited to announce a new team member!  Ed Gajewski joins Nuvera’s leadership team starting October 4, 2017.

Ed comes to Nuvera with a combined 25-year professional experience, 16 of which in the pharmaceutical industry.  Most recently, Ed worked for Novartis Pharmaceuticals Corporation where he held leadership roles in Patient Access, Marketing, Market Access, and Public Affairs in the USA and abroad.  Throughout his career he has launched new products, developed innovative approaches to distribution and industry leading patient access programs.  Ed has extensive experience across patient, physician, government / private payer, and specialty pharmacy segments.

Ed lives in Madison, NJ where he stays busy with his three children:  Ethan, Noah, and Hayley.  Ed grew up in the Midwest but now loves being close to NYC, the mountains and the ocean – but will always be a fan of the Green Bay Packers.  He has traveled extensively covering all 50 states and over 30 countries across 5 continents and bringing a broad experience to his work.

Ed earned an MBA, with honors, from Rutgers University and a Bachelor of Science from University of Wisconsin – Madison.

At Nuvera, Ed will focus on helping our current and future clients design and evolve award-winning Patient and HCP Support Services Programs that enhance patient experience and impact treatment outcomes.

This is how Ed explains his motivation for joining Nuvera: “Throughout my time working in the pharmaceutical industry I’ve seen that by deeply understanding the ‘patient journey’ and creating solutions for the ‘moments that matter’ an organization can directly impact the lives of patient, caregivers, and HCPs.  I, like almost everyone, have had friends and family members impacted by significant illness.  With my experience I could help them navigate our complex healthcare system.  The Nuvera mission is to help clients create programs and capabilities to deliver a seamless treatment experience so more patients can access available resources – this makes me excited to work with clients to deliver these patient-centric solutions.”

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Shazeen Rasheed Joins Nuvera Life Science Consulting as a Summer Intern!

Shazeen is a full-time MBA student at Rutgers Business School concentrating in Shazeen Rasheed web pharmaceutical management and marketing.

She has 10 years of professional experience in the automotive industry in Dubai, UAE, focused on marketing, strategy, and business development. She has been associated with leading automotive brands and has worked on several projects aimed at accelerating market growth.

Shazeen moved to the United States in 2014 and found herself intrigued by the pharmaceutical world and its ability to affect people’s lives positively on a global scale. She quickly realized that she could apply her creative problem-solving skills and diverse experience to the pharma consulting industry which helps build capabilities of manufacturers and other stakeholders in the healthcare landscape. This led her to Nuvera, where she will be working with industry experts committed to enhancing the patient experience.

Shazeen graduated with a degree in Business Studies from India but Dubai will always be home. In addition to pharmaceutical consulting, she hopes to enhance her foosball skills while at Nuvera and passionately believes that there is no such thing as too much Thai food.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera’s Highlights: Panagora Pharma Customer Experience Summit 2017

Nuvera_PanAgora Pharma CX Summit Presentation_2017-3-27_FinalNuvera was proud and excited to be a first-time sponsor, attendee, and presenter at the Pharma Customer Experience Summit 2017, hosted by Panagora Pharma March 28-29, 2017 at the
historic Grand Summit Hotel of Summit, NJ. Our message, and our approach to orchestrating an impactful experience for patients and providers, were well received and echoed sentiments expressed by other attendees.

Leading digital customer experience experts (including those from outside Pharma), senior-level members of industry, and professional marketers came together during the two-day Summit to answer the question: How can Pharma improve customer experience? The environment cultivated by all those in attendance helped promote discussion, collaboration and direction around evolving roles that technology, multi-channel marketing, pharmaceutical manufacturers, and more play in helping brands improve their customer experience in a strategic manner. Here are some of the highlights from the Summit we are happy to share:

  • Comprehensive Understanding of the Customer is Essential to Designing Effective and Empathetic Interaction – The mapping of and uncovering needs along customer experience journeys require a holistic approach to draw the insights necessary to bring innovation to brand marketing strategies and communication efforts. This includes familiarity, and connecting with the key emotional & behavioral drivers of patients throughout their experience, which affect everything from their interactions with providers, to treatment decisions, and adherence to therapy. It is becoming more common for organizations to utilize co-creation with their customers to solicit feedback, and truly understand customer needs in design phases, all as a means of bringing empathy into engagement
  • In the Age of Instant Content, Mastering Mobile Technology is Crucial – Pressures are mounting as more manufacturers come to realize that patients value unique content, and look to be provided with the content they want, when they want it. Experiences outside of Pharma are setting the bar for customer expectations, sometimes in ways that manufacturers are unable to meet. However, AI, chat functionality, virtual interactions, streamlined content creation, and a focus on digital & mobile resources are all opening the door for Pharma to become more capable of meeting this exponentially growing need to deliver a cohesive and consistent experience across multiple channels to meet customers where they are
  • Achieving Lasting Change Through Short-Term Pilot Efforts – Galvanizing internal leadership to change thinking around existing approaches to the customer experience is a challenge many organizations face, especially around ‘proof of concept’ to warrant investment and show ROI. This is more frequently being done through Prototype/Pilot concepts with clearly defined costs & success metrics set up front, as they are easier to implement, have measurable outcomes and are less permanent than large-scale change

Beyond, and including what is mentioned above, the Panagora Pharma Customer Experience Summit provided its attendees with a wealth of information and insights regarding the creation of enhanced and engaging experiences for patients and providers.

We’d be happy to walk you through our presentation ‘Don’t Just Deliver Support, Orchestrate and Experience‘ and discuss your organization’s Patient and Healthcare Provider Support Needs. Please contact us.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera at the American Pharmacists Association 2017 Meeting & Exposition

Nuvera was in attendance for the American Pharmacists Association (APhA) 2017 Meeting & Exposition held in San Francisco, CA from March 24-27, 2017. The meeting attracted over 7,000 attendees representing all pharmacist practice settings and over 150 exhibitors.

APhA’s theme for this year’s meeting was “Making an Impact in Patient Care.” The role that pharmacists play in positively impacting patient care throughout various practice settings is an integral and invaluable component in all patient journeys. This year’s theme resonates with Nuvera’s mission and philosophy of delivering more than just patient support – orchestrating a holistic experience in patient care.

The 4-day event was filled with educational and training sessions, the latest updates and news, networking, and adoption of new policy for the profession by the APhA House of Delegates.

Some of the key topics discussed during this year’s meeting included:

Provider status update

Rep. Earl L. “Buddy” Carter (R-GA), BSPharm, who is the only pharmacist in Congress and serves on the House Energy & Commerce Subcommittee on Health, spoke of the pharmacist provider status legislation making its way through Congress. “We’ve been doing this [pharmacists’ patient care services] for years,” he said. “You need to be recognized and compensated for it.” He noted that his office was meeting with the FDA next week about the possibility of a pharmacist-only class of medications.

http://pharmacistsprovidecare.com/

Opioids and the complex problem of addiction

“Inside America’s Opioid Epidemic: Pharmacists on the Frontlines” was the topic of the Opening General Session keynote address by Dr. Elliot J. Kran, MD, and professor of anesthesiology, perioperative, and pain medicine at Stanford University. Dr. Kran shared CDC statistics on addiction and discussed how the country’s pharmacists could potentially play a powerful role in reducing opioid addiction and drug-overdose deaths.

http://www.pharmacist.com/article/apha2017-opioids-and-complex-problem-addiction

Connect with patients and listen to their story

“80% of the time, it’s the patient’s story that determines his or her diagnosis” – 2nd General Session keynote speaker Dr. Leana Wen, MD, author of “When Doctors Don’t Listen”, emergency department doctor, and Baltimore City Health Commissioner, shared her stories that led her to become a patient advocate and how pharmacists are the “public face of health care.”

http://www.pharmacist.com/article/apha2017-connect-patients-and-listen-their-story

House of Delegates adopts policy related to pharmacists expanded roles.

As the profession continues to evolve, more than 300 delegates voted to adopt the policy from the APhA Policy Reference Committee on patient access to pharmacist-prescribed medications, pharmacists’ role within value-based payment models, and pharmacy performance networks.

http://www.pharmacist.com/article/house-delegates-adopts-policy-related-pharmacists-expanded-roles

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Welcome Ian Czop to Nuvera Life Science Consulting!

ianNuvera Life Science Consulting is excited to announce a new team member! Ian Czop joins Nuvera’s consulting team starting December, 2016.

Ian comes to Nuvera with a hybrid professional background of engineering and healthcare consulting. Most recently, in his healthcare consulting role at IMS Consulting Group, Ian was responsible for simultaneously managing multiple consulting projects related to global and domestic Pricing & Market Access for tier 1 pharmaceutical manufacturer products. Ian brings expertise in oncology, type 2 diabetes, and COPD/asthma therapeutic areas. Prior to his time at IMS, Ian interned at Bayer Pharmaceuticals within their Payer Marketing Group (market access), and was an engineering loss prevention consultant (and later account engineering manager) at FM Global between undergraduate and graduate school.

Ian lives in Montague, NJ where he retreats to get away from the bustling metropolis of his past lives, which include downtown Los Angeles and Manhattan. In his free time, Ian enjoys musical composition, personal fitness, attempting to cook, and snowboarding (weather permitting).

Ian graduated from the University of California, Irvine with a degree in Electrical Engineering in 2008, and from Cornell University in 2015 with an M.B.A.

At Nuvera, Ian will focus on helping our clients design and build award-winning Patient and HCP Support Services Programs.

Ian’s motivation for joining Nuvera:

My number one career goal currently is to help get life-saving therapies to the patients who require them the most. While working on payer access strategies at IMS proved to be a great entry into healthcare, my work was too far removed from the patient. At Nuvera, the team works directly on programs that are designed to create the optimal patient experience, including drug access, and presents a unique platform on which to build my expertise and career.”

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera’s Takeaways from CBI’s 8th Hub and SPP Model Optimization Conference

From February 22-23, 2017, CBI hosted their 8th HUB and SPP Model Optimization Conference in the history-rich city of Philadelphia, PA. Nuvera was not only proud to attend and sponsor the conference for the 4th time, but also was one of the speakers. Our mission and philosophy of delivering more than just patient support and orchestrating a holistic experience to provide a better foundation for patients and HCPs resonated very well with the attendees.

CBI’s specific focus this year was to bring together Manufacturers, HUB Service Providers and Data/Technology Providers together in order to create an environment where all who are involved in patient services could share and ideate on ways not only to enhance the patient care and support, but also to effectively connect the support to improved outcomes. Some of the key themes throughout the conference focused on:

  • Program Design is the Essential First Step in Successful Holistic Support – Allowing for ample time to design and build a program is key to implementation and operationalization as it allows the brand to focus on not only the needs of the patient but also on the specific patient population’s preferences to understand how they can access and utilize the services offered
  • White Glove Service is the Desired Direction for Patient Support– The term “White Glove” was used freely in several presentations, but few provided a definition of what this means specifically to the patient. Through conversations with other attendees, many concluded that while we all have the patient in mind when offering this up as the gold-standard for support, perhaps “White Glove” needs to be more clearly defined
  • Technology and Data Integration to Play an Important Role in Evolution of Hubs– Technology became an underlying theme throughout the conference as a backbone to building programs, offering services to patients, and allowing access to patient health records regardless of how many and where the patient is treated. EHR integration to patient support offerings was touted as the next significant step in technology advancement in patient support
  • Compliance Should be Considered Consistently During Program Build & Execution– Often overlooked, but potentially one of the most vital elements of designing, building and implementing patient support programs pertain to the legality and compliance of the programs. All manufactures need to put controls in place that ensure compliance standards are met across the spectrum of the program including but not limited to the stakeholders involved in the design and implementation of the program, the manner in which the patient is enrolled and the method the program is communicated to the HCPs or end-users
  • Patient Education Needs to be an Integral Component of Any Program – Ensuring patients can understand their benefits, medical vs. pharmacy, plans offered (high-deductible health plans) and market impact such as the Affordable Care and potential future changes to the market plays a key role in continued access to the drug

CBI’s 8th HUB and SPP Model Optimization Conference garnered an atmosphere of progressive thinking, creativity, and, most importantly, compassion for the patients we all serve.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera Presents at CBI’s 8th Hub & SPP Model Optimization Conference in Philadelphia, Feb 22

Don’t Just Deliver Support, Orchestrate an Experience! We are excited to speak at CBI’s 8th Hub and SPP Model Optimization Conference in Philadelphia, February 22-23. Join us as we discuss what it takes to build the right patient experience.

If you can’t make it to the conference, please stay tuned! We will post a summary of our presentation and the conference highlights on our blog.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Patient Support Program Success Factors

When it comes to successful execution of patient and provider support services, your hub may be the engine that drives program operations, but there is no one aspect that determines overall success. Instead, multiple factors working together deliver the ideal experience and hub execution is just one of them… and it may not be the most important.

Please download a pdf version of our Hub Optimization Infographic.

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera’s Highlights from CBI’s 7th Hub and SPP Model Optimization Conference

Nuvera had the opportunity to sponsor and attend CBI’s 7th Hub and SPP Model Optimization Conference held in San Diego September 29-30, 2016. The general focus of the conference was to discuss key strategies for designing and optimizing Hub programs to deliver patient support services that maximize product access and therapy compliance. There was definitely a common theme across the presenters: understanding the desired patient/treatment experience – and identifying the right set of support services to enable that experience – are paramount to successful execution by the Hub. As well, successful execution follows a carefully crafted vision and strategy for patient support services. Several quick highlights we thought worth sharing:

HUB Execution is Just One of the Program Success Factors: When it comes to successful execution of patient and provider support services, the Hub may be the engine that drives program operations, but there is no one aspect that determines overall success. Multiple factors working together deliver the ideal experience and Hub execution is just one of them. And, it may not be the most important…
Ultimately, success of the Patient/HCP Support Program is determined by the following factors:

  • Design – How do you validate that you have the right services to meet customers’ needs?
  • Operations – How do you ensure you have the best systems, processes, and partners to execute?
  • Pull Through – How are field resources coordinated to set expectations and deliver support?
  • Feedback – What mechanisms derive continuous insights for improvement and satisfaction?

Key Takeaway: Manufacturers would benefit from having holistic diagnostics that evaluate support program performance against KPIs beyond just Hub execution – and consider the factors above.

Solid Understanding of the Desired Treatment Experience is a Prerequisite for Evolution to eHubs: The market is beginning to offer many robust e-solutions to optimize Hub performance. However, as one of the speakers noted, the “e” in eHubs doesn’t stand for easy. Diagnosing the root cause of underperformance, setting the vision for the desired patient/HCP experience, and identifying the right services to remove barriers along the patient journey are still paramount to choosing the right solution.

Key Takeaway: Sample factors that should be taken into account while defining the vision and requirements for eSolutions:

  • Challenges created/not addressed by products attributes and disease state
  • Complexity of, and number of different support elements needed to ensure successful treatment outcomes (eg, Dx, monitoring, dosage, administration, etc.)
  • Patient population, behavioral segmentation, and resulting needs
  • Existing competitive patient/HCP support efforts
  • Anticipated patient volume and duration of therapy
  • Internal and external partner capabilities to deliver the support experience

Download a pdf version of our Hub Optimization Infographic here.

We’ll be presenting at the upcoming CBI 8th HUB and SPP Model Optimization Conference in Philadelphia February 22-23, 2017. Come out and join us!

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com

Nuvera’s Highlights from CBI’s Patient Journey Mapping Conference

Nuvera recently had the opportunity to sponsor and attend CBI’s conference on Patient Journey Mapping held in Philadelphia August 15th & 16th. The general focus of the conference was to discuss key enablement components along the journey from diagnosis to adherence. Several quick highlights we thought worth sharing:

SP Field Force & Data Exchange: Manufacturer coordination with Specialty Pharmacies (SP) and their sales teams was discussed as a key issue to focus on and resolve. Oftentimes the SP sales reps are communicating different messages than brand sales or field support coordinators, creating misaligned customer interactions. Also, communications/data between brand programs and SPs are not always seamless, leading to experience disconnects for patients & HCPs. Manufacturers are encouraged to develop a solid understanding of SP activities and proactively engage with them (even outside contract situations) to ensure understanding and/or alignment on respective efforts and focus on the end customer.

Revolution of eBI and ePA: As progress in technology and efficiency is changing the society and the way we live, it is also making inroads into the pharmaceutical industry. Two areas that are specifically impacting the speed to therapy for patients are eBI (electronic Benefits Investigation) and ePA (electronic prior authorization). Traditionally, both of these activities have been done manually by expert hub personnel, with turnaround times usually around 48 hours for a BI and several days to coordinate support for a PA. Today, with eBI/ePA, that time can be drastically shortened to a matter of minutes for BIs and a day to effectively coordinate a PA with the use of automated electronic formats. However, the overall adoption rate of this technology continues to be slow as integration of these tools within existing EHR platforms has been difficult to accomplish due to ongoing EHR fragmentation.

Patient Journey Concept & Alignment: It quickly became clear that there isn’t one universal interpretation of what a ‘patient journey’ is. The focus and the depth of the patient journey concept differed greatly between conference participants with some equating the patient journey with only the emotional aspects of diagnosis/treatment while others focused simply on the clinical pathway. In the end, Nuvera feels strongly that the patient journey is much broader than just emotions or clinical steps – it incorporates all the aspects (emotional, functional, clinical, etc.) of understanding of what happens to a patient, their caregiver, and their providers along each step of the diagnosis, onboarding, and adherence to a therapy. Without this holistic view and focus, most patient journey work becomes simply one strategic input of many, vs. the very foundation from which brand teams and organizations should be building their overall strategy and support interactions.

How is your company using the patient journey? Is the patient journey helping you in aligning the internal stakeholders within your organization and improving the customer experience?

Please read Nuvera’s post: Make Your Patient’s Journey the Foundation of the Brand Experience, Not Just Another Strategic Input

About Nuvera:

Nuvera dedicates itself to helping specialty pharmaceutical, biotech and rare disease companies to design and deliver a seamless patient and HCP experience for specialty therapies. Over the last 8 years, Nuvera has helped over 15 pharmaceutical companies to create and implement leading Patient-Centric solutions across 24 specialty therapeutic areas that received over 10 U.S. and Global excellence awards.

Nuvera services include the following:
• Uncover and crystalize patient and healthcare provider (HCP) needs
• Design impactful patient/HCP support experiences
• Build patient support programs and capabilities
• Optimize program performance

To learn more, please visit www.nuveracg.com